Annual SGA
$288.93 M
+$138.34 M+91.87%
December 31, 2024
Summary
- As of March 12, 2025, BBIO annual SGA is $288.93 million, with the most recent change of +$138.34 million (+91.87%) on December 31, 2024.
- During the last 3 years, BBIO annual SGA has risen by +$96.72 million (+50.32%).
- BBIO annual SGA is now at all-time high.
Performance
BBIO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$94.78 M
+$25.96 M+37.73%
December 31, 2024
Summary
- As of March 12, 2025, BBIO quarterly SGA is $94.78 million, with the most recent change of +$25.96 million (+37.73%) on December 31, 2024.
- Over the past year, BBIO quarterly SGA has increased by +$25.96 million (+37.73%).
- BBIO quarterly SGA is now at all-time high.
Performance
BBIO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$11.19 B
-$535.76 M-5.03%
December 31, 2024
Summary
- As of March 12, 2025, BBIO TTM SGA is -$11.19 billion, with the most recent change of -$535.76 million (-5.03%) on December 31, 2024.
- Over the past year, BBIO TTM SGA has dropped by -$11.43 billion (-4730.07%).
- BBIO TTM SGA is now -6137.25% below its all-time high of -$179.44 million.
Performance
BBIO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
BBIO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +91.9% | +37.7% | -4730.1% |
| 3 y3 years | +50.3% | +37.7% | -4730.1% |
| 5 y5 years | +206.2% | +37.7% | -4730.1% |
BBIO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +101.8% | at high | +204.7% | -128.5% | at low |
| 5 y | 5-year | at high | +206.2% | at high | +204.7% | -718.5% | at low |
| alltime | all time | at high | +2072.1% | at high | +1083.7% | -6137.3% | at low |
BridgeBio Pharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $288.93 M(+91.9%) | $94.78 M(+37.7%) | $288.93 M(+19.5%) |
| Sep 2024 | - | $68.82 M(+15.6%) | $241.73 M(+15.8%) |
| Jun 2024 | - | $59.52 M(-9.5%) | $208.69 M(+12.6%) |
| Mar 2024 | - | $65.81 M(+38.3%) | $185.29 M(+23.0%) |
| Dec 2023 | $150.59 M(+5.2%) | $47.58 M(+33.0%) | $150.59 M(+11.7%) |
| Sep 2023 | - | $35.78 M(-1.0%) | $134.87 M(+3.5%) |
| Jun 2023 | - | $36.12 M(+16.1%) | $130.28 M(-0.2%) |
| Mar 2023 | - | $31.11 M(-2.4%) | $130.58 M(-8.8%) |
| Dec 2022 | $143.19 M(-25.5%) | $31.86 M(+2.2%) | $143.19 M(-13.8%) |
| Sep 2022 | - | $31.19 M(-14.4%) | $166.08 M(-8.2%) |
| Jun 2022 | - | $36.43 M(-16.7%) | $180.97 M(-5.0%) |
| Mar 2022 | - | $43.71 M(-20.2%) | $190.52 M(-0.9%) |
| Dec 2021 | $192.21 M | $54.75 M(+18.8%) | $192.21 M(+9.9%) |
| Sep 2021 | - | $46.08 M(+0.2%) | $174.90 M(+6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $45.97 M(+1.2%) | $164.83 M(+5.1%) |
| Mar 2021 | - | $45.41 M(+21.3%) | $156.83 M(+7.7%) |
| Dec 2020 | $145.68 M(+54.4%) | $37.44 M(+3.9%) | $145.68 M(+1.7%) |
| Sep 2020 | - | $36.02 M(-5.1%) | $143.22 M(+9.6%) |
| Jun 2020 | - | $37.97 M(+10.8%) | $130.70 M(+19.1%) |
| Mar 2020 | - | $34.26 M(-2.0%) | $109.72 M(+16.3%) |
| Dec 2019 | $94.35 M(+116.5%) | $34.97 M(+48.8%) | $94.35 M(+27.9%) |
| Sep 2019 | - | $23.50 M(+38.3%) | $73.76 M(+21.8%) |
| Jun 2019 | - | $16.99 M(-10.1%) | $60.58 M(+11.2%) |
| Mar 2019 | - | $18.90 M(+31.4%) | $54.48 M(+25.0%) |
| Dec 2018 | $43.59 M(+227.7%) | $14.38 M(+39.5%) | $43.59 M(+49.2%) |
| Sep 2018 | - | $10.31 M(-5.4%) | $29.21 M(+54.5%) |
| Jun 2018 | - | $10.89 M(+36.0%) | $18.90 M(+136.0%) |
| Mar 2018 | - | $8.01 M | $8.01 M |
| Dec 2017 | $13.30 M | - | - |
FAQ
- What is BridgeBio Pharma annual SGA?
- What is the all time high annual SGA for BridgeBio Pharma?
- What is BridgeBio Pharma annual SGA year-on-year change?
- What is BridgeBio Pharma quarterly SGA?
- What is the all time high quarterly SGA for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly SGA year-on-year change?
- What is BridgeBio Pharma TTM SGA?
- What is the all time high TTM SGA for BridgeBio Pharma?
- What is BridgeBio Pharma TTM SGA year-on-year change?
What is BridgeBio Pharma annual SGA?
The current annual SGA of BBIO is $288.93 M
What is the all time high annual SGA for BridgeBio Pharma?
BridgeBio Pharma all-time high annual SGA is $288.93 M
What is BridgeBio Pharma annual SGA year-on-year change?
Over the past year, BBIO annual SGA has changed by +$138.34 M (+91.87%)
What is BridgeBio Pharma quarterly SGA?
The current quarterly SGA of BBIO is $94.78 M
What is the all time high quarterly SGA for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly SGA is $94.78 M
What is BridgeBio Pharma quarterly SGA year-on-year change?
Over the past year, BBIO quarterly SGA has changed by +$25.96 M (+37.73%)
What is BridgeBio Pharma TTM SGA?
The current TTM SGA of BBIO is -$11.19 B
What is the all time high TTM SGA for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM SGA is -$179.44 M
What is BridgeBio Pharma TTM SGA year-on-year change?
Over the past year, BBIO TTM SGA has changed by -$11.43 B (-4730.07%)